Navigation Links
BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board

QUINCY, Mass., Oct. 7 /PRNewswire/ -- BioEnergy International, LLC (BioEnergy), a privately-held, biotech developer and manufacturer of next-generation, renewable biochemicals and biofuels, announces the addition of Norman R. Augustine to its Board of Advisors effective December 2008. Mr. Augustine has a record of distinguished leadership and innovation at the highest level of industry and government culminating in his role as Chairman and Chief Executive Officer of Lockheed Martin, the nation's largest aerospace/defense company.

(Logo: )

"I am honored and excited by Dr. Augustine joining our Board of Directors. He is a man of truly remarkable talents in science, engineering and public policy, and beyond that, a man distinguished by his service to all Americans whether as Chairman of the American Red Cross, President of the Boy Scouts or as Under Secretary of the Army," said Stephen J. Gatto, Chairman and Chief Executive Officer of BioEnergy. "We look forward to Mr. Augustine bringing his exceptional vision, experience and guidance to BioEnergy as we transform the chemicals and fuels markets with our bio-based platform."

"I believe BioEnergy's proven, disruptive, sustainable technology and strong management holds great potential," said Norman R. Augustine. "I am excited to begin working with the firm to help capitalize on this important opportunity."

Mr. Augustine is a current or former member of the Board of Directors of ConocoPhillips, Black & Decker, Proctor & Gamble and Lockheed Martin, and of the Board of Trustees of Colonial Williamsburg. He is a Regent of the University System of Maryland, Trustee Emeritus of Johns Hopkins and a former member of the Board of Trustees of MIT and Princeton, his alma mater. He is an Advisory Board member to the Department of Homeland Security, was a member of the Hart/Rudman Commission on National Security, and has served for 16 years on the President's Council of Advisors on Science and Technology. He has been presented the National Medal of Technology and received the Joint Chiefs of Staff Distinguished Public Service Award and is a five time recipient of the Department of Defense's Civilian Distinguished Service Medal.

Mr. Augustine co-authored The Defense Revolution and Shakespeare In Charge and is the author of Augustine's Laws and Augustine's Travels. He was selected by Who's Who in America and the Library of Congress as one of "Fifty Great Americans". He was Chairman and Principal Officer of the American Red Cross for nine years, Chairman of the National Academy of Engineering, President and Chairman of the Association of the United States Army, Chairman of the Aerospace Industries Association, and Chairman of the Defense Science Board. He is a former President of the American Institute of Aeronautics and Astronautics and the Boy Scouts of America. He has participated in a number of studies of future energy alternatives.

Mr. Augustine joins existing Advisory Board members Robert McFarlane and Chairman R. James Woolsey. "Having known and worked with Norm Augustine for many years, I can't think of a better resource for BioEnergy to draw upon in order to realize its vast potential," said Mr. Woolsey. "He is a most welcome addition to this exciting team."

"We've been fortunate in America to have produced leaders in each generation who combine scientific excellence and civic virtue with a prescient understanding of 'what we need most right now' to preserve growth and prosperity in our country; Norm Augustine is such a man. Bio-Energy is fortunate to have him on their board," said Robert "Bud" McFarlane, President Ronald Reagan's former National Security Advisor and fellow board member.

BioEnergy's Advisory Board advises the company's Board of Directors and management in the Company's strategic decision making process and other matters including business and organizational development, technology, policy and outreach.

About BioEnergy

Led by a world-renowned team of molecular biologists, engineers, and chemists, BioEnergy utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable production of high-value specialty chemicals and renewable fuels. The company's strategic vision is to replace a barrel of crude with a pound of sugar derived from waste for the manufacture of everything from the fuel we put in our cars to the plastics and fabrics we use in our everyday lives. For more information, visit

Contact: Samuel G. McConnell, Sr.VP, Corporate Development

(617) 657-5200

SOURCE BioEnergy International, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
2. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
3. Raj Khankari Named Bioenergy, Inc., CEO
4. Atlantica BioEnergy Task Force Unveiled
5. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
6. BioEnergy International Facility Opens in Bay State
7. Biomaxx Systems Inc. Renews Membership With Bioenergy Australia
8. China Yingxia International, Inc. Appoints New Vice President of Finance
9. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
10. Sangui BioTech International, Inc. Files Remaining Reports
11. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... 2015  Clintrax Global, Inc., a worldwide provider of clinical research ... announced that the company has set a new quarterly earnings record ... quarter growth posted for Q3 of 2014 to Q3 of 2015. ... Mexico , with the establishment of an Asia-Pacific ... United Kingdom and Mexico ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
Breaking Biology Technology:
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
Breaking Biology News(10 mins):